Press Release
“Yudh Pradushan ke Virudh” Amidst COVID: CM schemes For 13 Hotspots, Mobile Application
Anti-Air Pollution campaign "Yudh Pradushan ke Virudh." Government developing a "Green Delhi" mobile application. Alternatives for stubble burning and steps...
Read more
India, South Africa propose waiver of patent rights under TRIPS for COVID-19 containment
India, South Africa seek a time-bound waiver of IP, patents' protection under the TRIPS Agreement of WTO WTO asked to...
Read more
Controversial Testing Guidance given by C.D.C. raises suspicion
THD HelpDesk, Atlanta: A general guidance was published last month, by the Centers for Disease Control and Prevention last month in...
Read more
CCI approves Piramal-Carlyle merger, closes deal at 3700 Crores
THD NewsDesk, NEW DELHI: The Competition Commission of India (CCI) has finally approved the amalgamation of Piramal Pharma Ltd and...
Read moreJardiance® meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in phase III trial in adults with and without diabetes
RIDGEFIELD, Conn. and INDIANAPOLIS, July 30, 2020 /PRNewswire/ -- Positive top-line results from the EMPEROR-Reduced phase III trial in adults with heart failure with reduced ejection...
Read moreMicroOptx Completes Patient Enrollment in Initial Phase of U.S. Pivotal Clinical Trial for the Beacon Aqueous Microshunt
MINNEAPOLIS, July 30, 2020 /PRNewswire/ -- MicroOptx Inc., a medical device innovator with a platform technology to change the way the world...
Read moreSingle Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
NEW BRUNSWICK, N.J., July 30, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced that its lead vaccine candidate protected against...
Read moreCytoSorbents Awarded $4.4 Million Contract by the U.S. Department of Defense to Complete HemoDefend-BGA Adsorber Preclinical Development
MONMOUTH JUNCTION, N.J., July 31, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader specializing in blood purification, announced today that the...
Read more
